期刊文献+

牙周治疗对伴动脉粥样硬化牙周炎白细胞介素6及基质金属蛋白酶影响的动物实验 被引量:21

Influence of periodontal therapy on serum interleukin-6 and carotid metalloproteinases in animals with chronic periodontitis associated with atherosclerosis
原文传递
导出
摘要 目的 通过研究牙周基础治疗对伴动脉粥样硬化(atherosclerosis,As)慢性牙周炎(chronic periodontitis,CP)大鼠的影响,以期为临床提供参考.方法 44只清洁级SD大鼠按随机数字表法随机分为A组(正常对照组,7只)、B组(As组,建立As模型,8只)及C组(CP+ As组,建立CP+ As模型,29只).建模后将C组再应用随机数字表法分为4个小组,CI组:自然进程组,C2组:单纯机械治疗组,C3组:机械治疗+盐酸米诺环素(派丽奥)组,C4组:机械治疗+盐酸米诺环素+抗生素组,每组7只.建模后15周按随机数字表法处死B、C组大鼠各1只,分别进行血管病理切片发现有脂质沉积形成,同时观察C组大鼠口腔出现牙周炎表现,证明As及CP+ As建模成功,开始口腔干预.分别于建模后第1、3、5、7和9周应用酶联免疫吸附测定法检测血清中白细胞介素6(interleukin-6,IL-6)的浓度,免疫组化法定性检测各组大鼠颈动脉血管壁组织的基质金属蛋白酶(matrix metalloproteinase,MMP)2、MMP-9并测量其灰度值.结果 各组MMP-2,9的灰度值趋势基本一致,B、C组颈动脉的内膜、中膜阳性染色深度均明显大于A组.C1组(MMP-2,9的灰度值分别为101.3±2.4、101.2±4.1)有As斑块形成,染色深度明显强于B组(MMP-2,9的灰度值分别为12.6.4±2.0、124.8±2.8)(P<0.05);C2、C3和C4组染色范围及程度依次减弱,且均弱于C1组,与C1组的灰度值相比差异均有统计学意义(P<0.05).血清检测结果显示,随着时间推移,B、C1组血清IL-6浓度一直呈升高趋势,均显著高于A组(P<0.01);C2、C3、C4组血清IL-6浓度均为先升后降,在建模后第5周达峰值,其中C2组最高,从第4次取样时间点起,各组IL-6含量均显著低于C1组(P<0.001),C3、C4组显著低于C2组(P<0.01).结论 对于伴有As的CP大鼠,若不及时控制CP,可能会加重As的病变程度;牙周机械治疗可能会短期内增高机体炎症反应程度,而长期则可能降低血管炎症,减缓其As病变程度;牙周机械治疗时辅以局部及全身抗炎药物后,颈动脉血管病变及全身炎症可以得到更好的改善. Objective To investigate the effect of periodontal mechanical treatment on serum interleukin-6 (IL-6) and carotid artery matrix metalloproteinase(MMP)-2 and MMP-9 expression in chronic periodontitis(CP) SD rats with atherosclerosis (As).Methods Forty-four six-week-old male SD rats were randomly divided into three groups:control group(group A),As group (group B),As + CP group (group C).According to different periodontal interventions,group C was randomly subdivided into four groups:natural process group (C 1),the periodontal mechanical treatment group (C2),the periodontal mechanical treatment + local drugs group(C3),and the periodontal mechanical treatment + local and system drugs group(C4).Each group received the appropriate treatment and periodontal interventions.Serum IL-6 levels were determined by enzyme linked immunosorrbent assay (ELISA).MMP-2 and MMP-9 levels in the proximal aorta were examined by immunohistochemistry.Results The gray value of MMP-2 and MMP-9 was basically the same in all groups.Compared with group A,the gray value of MMP-2 and MMP-9 of group B and C were decreased.C1 group showed the formation of atherosclerotic plaque and fibrous cap.Compared with group B (126.4 ± 2.0,124.8 ± 2.8),the gray value of group C1 (101.3 ± 2.4,101.2 ± 4.1) was significantly weaker(P < 0.05).The staining depth of MMP-2 and MMP-9 of groups C1,C2,C3 and C4 were sequentially decreased,and the differences of gray value were statistically significant(P < 0.05).The levels of serum IL-6 in groups B and C1 increased gradually with time and became significantly higher than that of group A(P < 0.01).The levels of serum IL-6 in groups C2,C3,and C4 increased gradually and reached the peak 5 weeks after the establishment of model (P < 0.001).After that,the levels of serum IL-6 decreased gradually and was lower than baseline.The levels of serum IL-6 in groups C3 and C4 were significantly lower than that in group C2 7 weeks after the establishment of model(P < 0.01).Conclusions In rats with periodontitis and cardiovascular diseases,chronic periodontal inflammation may significantly increase the severity of As and promote the formation of atherosclerotic plaque.Mechanical periodontal therapy may cause short-term systemic inflammation and then reduce vascular inflammation in long term.With supplement use of local and systemic antibiotics,the mechanical periodontal therapy may get the vascular disease and systemic inflammation improved.
出处 《中华口腔医学杂志》 CAS CSCD 北大核心 2014年第3期155-160,共6页 Chinese Journal of Stomatology
基金 国家自然科学基金(81271144、31050002) 山西省自然科学基金(2010011050-1)
关键词 牙周炎 动脉粥样硬化 基质金属蛋白酶类 白细胞介素6 牙周基础治疗 Periodontitis Atherosclerosis Metalloproteinases Interleukin-6 Periodontal mechanical therapy
  • 相关文献

参考文献12

  • 1Demmer RT,Papapanou PN.Epidemiologic patterns of chronic and aggressive periodontitis[J].Periodontol 2000,2010,53 (1):28-44.
  • 2Roger VL,Go AS,Lloyd-Jones DM,et al.Heart disease and stroke statistics:2012 update:a report from the American Heart Association[J].Circulation,2012,125 (1):e2-e220.
  • 3Galis ZS,Sukhova GK,Lark MW,et al.Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques[J].J Clin Invest,1994,94 (6):2493-2503.
  • 4Stintzing S,Heuschmann P,Barbera L,et al.Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae,inflammation,and apoptosis[J].Ann Vasc Surg,2005,19 (3):310-319.
  • 5Choi ET,Collins ET,Marine LA,et al.Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injuryinduced accelerated atherosclerotic plaque development in apolipoprotein E-deficient mice[J].Arterioscler Thromb Vasc Bio1,2005,25 (5):1020-1025.
  • 6Lockhart PB,Bolger AF,Papapanou PN,et al.Periodontal disease and atherosclerotic vascular disease:does the evidence support an independent association?:a scientific statement from the American Heart Association[J].Circulation,2012,125 (20):2520-2544.
  • 7孙丽莉,石学雪,任秀云,常乐,林牧,岳姿洁.牙周干预措施对动脉粥样硬化影响的实验动物研究[J].中华口腔医学研究杂志(电子版),2012,6(3):28-33. 被引量:6
  • 8Voils SA,Evans ME,Lane MT,et al.Use of macrolides and tetracyclines for chronic inflammatory diseases[J].Ann Pharmacother,2005,39(1):86-94.
  • 9高云,钟良军,张源明,周晓欢,梁平,徐隽.兔慢性牙周炎合并动脉粥样硬化血清炎性因子变化及替硝唑对其的影响[J].中华实用诊断与治疗杂志,2011,25(7):660-663. 被引量:4
  • 10段晋瑜,欧阳翔英,周于翔.中、重度慢性牙周炎伴高血脂患者在牙周基础治疗后血脂的变化[J].北京大学学报(医学版),2009,41(1):36-39. 被引量:23

二级参考文献50

  • 1张源明,钟良军,何秉贤,聂晶,王璇,李文超.冠心病和慢性牙周炎相关性研究[J].中华流行病学杂志,2006,27(3):256-259. 被引量:72
  • 2王岩,吴忠荣,尚姝环,董维理,李中琴,李化,李成章.武汉市公务员血脂水平与牙周炎相关性的调查研究[J].牙体牙髓牙周病学杂志,2007,17(1):33-36. 被引量:14
  • 3梁皓,赵文增.重要炎症因子与冠心病的关系[J].实用诊断与治疗杂志,2007,21(5):364-366. 被引量:27
  • 4Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group[ J ]. N Engl J Med, 1995, 333(20) : 1301 - 1307.
  • 5Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/ Texas Coronary Atherosclemsis Prevention Study [ J ]. JAMA, 1998, 279(20) : 1615 - 1622.
  • 6The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [ J]. Lancet, 1994, 344(8934) : 1383 - 1389.
  • 7Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels cholesterol and recurrent events trial investigators[J]. N Engl J Med, 1996, 335 (14): 1001-1009.
  • 8The Long-Term Intervention with Pravastatin in Ischaemic Disease (L IP-D) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels [ J ]. N Engl J Med, 1998, 339(19) : 1349 -1357.
  • 9Mattila KJ, Nieminen M, Valtonen V, et al. Association between dental health and acute myocardial infarction [ J ]. BMJ, 1989, 298 (6676) : 779 -785.
  • 10De Stefano F, Anda RF, Kahn HS, et al. Dental disease and risk of coronary heart disease and mortality [ J ] . BMJ, 1993, 306 (6879) : 688 -697.

共引文献29

同被引文献181

引证文献21

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部